Gene: SCPEP1
Official Full Name: serine carboxypeptidase 1provided by HGNC
Gene Summary: Predicted to enable serine-type carboxypeptidase activity. Predicted to be involved in negative regulation of blood pressure and retinoic acid metabolic process. Predicted to act upstream of or within blood vessel diameter maintenance. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14305 | SCPEP1 Knockout cell line (HeLa) | Human | SCPEP1 | 1:3~1:6 | Negative | Online Inquiry |
KO14306 | SCPEP1 Knockout cell line (HCT 116) | Human | SCPEP1 | 1:2~1:4 | Negative | Online Inquiry |
KO14307 | SCPEP1 Knockout cell line (HEK293) | Human | SCPEP1 | 1:3~1:6 | Negative | Online Inquiry |
KO14308 | SCPEP1 Knockout cell line (A549) | Human | SCPEP1 | 1:3~1:4 | Negative | Online Inquiry |
SCPEP1 Gene Knockout Cell Lines are a specialized collection of genetically engineered cell lines designed to facilitate the study of the SCPEP1 gene, which encodes for a significant component involved in various biological processes including cell signaling and immune response. These knockout cell lines have been meticulously crafted utilizing CRISPR-Cas9 technology, rendering them invaluable tools for researchers investigating the role of SCPEP1 in cellular functions and pathology.
The primary function of these knockout cell lines is to provide a controlled environment that allows for the observation of phenotypic and functional changes in the absence of SCPEP1. By eliminating the gene, researchers can elucidate its contributions to cellular mechanisms, such as apoptosis, proliferation, and differentiation. The precise gene editing performed in these cell lines ensures they serve as accurate models for both basic biology and therapeutic research, resulting in high-relevance data that can lead to groundbreaking discoveries.
The scientific importance of SCPEP1 Gene Knockout Cell Lines extends to numerous applications, including drug discovery, understanding genetic diseases, and elucidating disease mechanisms at the cellular level. These cell lines can be particularly crucial in translational research, where findings can inform clinical strategies for treating conditions linked to SCPEP1 dysfunction.
Compared to alternative models, such as whole organisms or the use of RNA interference, SCPEP1 Gene Knockout Cell Lines present distinct advantages. They offer a more specific and controllable system to study gene function without the variability that can arise from in vivo experiments. Additionally, these cell lines can be easily expanded for large-scale studies, saving both time and resources.
For researchers and clinicians, the value of SCPEP1 Gene Knockout Cell Lines lies not only in their ability to deliver precise and reproducible results, but also in their role in accelerating the discovery of new therapeutic targets. By utilizing this product, users can deepen their understanding of gene-function relationships and explore innovative approaches to treatment and diagnosis.
With a commitment to excellence and years of experience in providing cutting-edge biological products, our company stands as a trusted leader in the field, ensuring that our offerings meet the highest standards of quality and efficacy for scientific research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.